메뉴 건너뛰기




Volumn 50, Issue 8, 2009, Pages 1301-1307

Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody

Author keywords

GC phenotype; Lymphoma; MMP 2; MMP 9; prognosis; TIMP 1

Indexed keywords

CD20 ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GELATINASE A; GELATINASE B; PREDNISOLONE; PREDNISONE; RITUXIMAB; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VINCRISTINE; ANTINEOPLASTIC AGENT; CHOEP PROTOCOL; CHOP PROTOCOL; MONOCLONAL ANTIBODY; TUMOR PROTEIN;

EID: 77649295960     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903003244     Document Type: Article
Times cited : (8)

References (37)
  • 1
    • 1842413105 scopus 로고    scopus 로고
    • The Non-Hodgkin's lymphoma classification project
    • A clinical evaluation of the international Lymphoma Study Group classification of non-Hodgkin's lymphoma
    • A clinical evaluation of the international Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909-3918.
    • (1997) Blood , vol.89 , pp. 3909-3918
  • 2
    • 0031927984 scopus 로고    scopus 로고
    • New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes
    • Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histological subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16:2780-2795. (Pubitemid 28363044)
    • (1998) Journal of Clinical Oncology , vol.16 , Issue.8 , pp. 2780-2795
    • Armitage, J.O.1    Weisenburger, D.D.2
  • 3
    • 0027444652 scopus 로고
    • The international non-Hodgkin's lymphoma prognostic factor project
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factor Project. N Engl J Med 1993;329:987-994.
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 6
    • 15244348390 scopus 로고    scopus 로고
    • Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
    • DOI 10.1016/j.biochi.2005.01.014
    • Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and MMP-9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 2005;87:287-297. (Pubitemid 40387607)
    • (2005) Biochimie , vol.87 , Issue.SPEC. ISS. , pp. 287-297
    • Turpeenniemi-Hujanen, T.1
  • 7
    • 15244339896 scopus 로고    scopus 로고
    • The absence of immunoreactivity for tissue inhibitor of metalloproteinase-1 (TIMP-1), but not for TIMP-2, protein is associated with a favorable prognosis in aggressive breast carcinoma
    • DOI 10.1159/000086774
    • Kuvaja P, Talvensaari-Mattila A, Pääkkö P, et al. The absence of immunoreactivity for tissue inhibitor of metalloproteinase-1 (TIMP-1) but not for TIMP-2 protein is associated with a favourable prognosis in aggressive breast carcinoma. Oncology 2005;68:196-203. (Pubitemid 41158976)
    • (2005) Oncology , vol.68 , Issue.2-3 , pp. 196-203
    • Kuvaja, P.1    Talvensaari-Mattila, A.2    Paakko, P.3    Turpeenniemi-Hujanen, T.4
  • 8
    • 18244390735 scopus 로고    scopus 로고
    • Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and week squamous cell carcinoma: Comparison of the circulating and tissue immunoreactive protein
    • DOI 10.1158/1078-0432.CCR-04-2277
    • Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin Cancer Res 2005;11:3257-3264. (Pubitemid 40627873)
    • (2005) Clinical Cancer Research , vol.11 , Issue.9 , pp. 3257-3264
    • Ruokolainen, H.1    Paakko, P.2    Turpeenniemi-Hujanen, T.3
  • 9
    • 30944455693 scopus 로고    scopus 로고
    • Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma - Tissue immunoreactivity predicts aggressive clinical course
    • DOI 10.1038/modpathol.3800506, PII 3800506
    • Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma - tissue immunoreactivity predicts aggressive clinical course. Mod Pathol 2006;19:208-217. (Pubitemid 43117605)
    • (2006) Modern Pathology , vol.19 , Issue.2 , pp. 208-217
    • Ruokolainen, H.1    Paakko, P.2    Turpeenniemi-Hujanen, T.3
  • 11
    • 0041627545 scopus 로고    scopus 로고
    • Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomas
    • DOI 10.1034/j.1600-0609.2003.00101.x
    • Kuittinen O, Apaja-Sarkkinen M, Turpeenniemi-Hujanen T. Gelatinases (MMP-2, MMP-9), TIMP-1 expression and extent of neovascularization in aggressive non-Hodgkin's lymphomas. Eur J Haematol 2003;71:91-99. (Pubitemid 36951641)
    • (2003) European Journal of Haematology , vol.71 , Issue.2 , pp. 91-99
    • Kuittinen, O.1    Apaja-Sarkkinen, M.2    Turpeenniemi-Hujanen, T.3
  • 13
    • 33745207537 scopus 로고    scopus 로고
    • Clinicopathological implications of tissue inhibitor of metalloproteinase-1-positive diffuse large B-cell lymphoma
    • Choi JW, An JS, Lee JH, et al. Clinicopathological implications of tissue inhibitor of metalloproteinase-1-positive diffuse large B-cell lymphoma. Mod Pathol 2006;19:963-973.
    • (2006) Mod Pathol , vol.19 , pp. 963-973
    • Choi, J.W.1    An, J.S.2    Lee, J.H.3
  • 16
    • 34249673388 scopus 로고    scopus 로고
    • Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy
    • DOI 10.1182/blood-2006-09-047068
    • Nyman H, Adde M, Karjalainen-Lindsberg ML, et al. Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood 2007;109:4930-4935. (Pubitemid 46827791)
    • (2007) Blood , vol.109 , Issue.11 , pp. 4930-4935
    • Nyman, H.1    Adde, M.2    Karjalainen-Lindsberg, M.-L.3    Taskinen, M.4    Berglund, M.5    Amini, R.-M.6    Blomqvist, C.7    Enblad, G.8    Leppa, S.9
  • 19
    • 57149089307 scopus 로고    scopus 로고
    • Stromal gene signatures in large-B-cell lymphomas
    • Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008;359:2313-2323.
    • (2008) N Engl J Med , vol.359 , pp. 2313-2323
    • Lenz, G.1    Wright, G.2    Dave, S.S.3
  • 20
    • 54049126176 scopus 로고    scopus 로고
    • Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: An international collaborative study
    • Young KH, Leroy K, Møller MB, et al. Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood 2008;112:3088-3098.
    • (2008) Blood , vol.112 , pp. 3088-3098
    • Young, K.H.1    Leroy, K.2    Møller, M.B.3
  • 21
    • 3042776316 scopus 로고    scopus 로고
    • Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma - A Nordic Lymphoma Group study
    • DOI 10.1007/s00277-004-0855-x
    • Jerkeman M, Anderson H, Dictor M, et al. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma - a Nordic Lymphoma Group study. Ann Hematol 2004;83:414-419. (Pubitemid 38877961)
    • (2004) Annals of Hematology , vol.83 , Issue.7 , pp. 414-419
    • Jerkeman, M.1    Anderson, H.2    Dictor, M.3    Kvaloy, S.4    Akerman, M.5    Cavallin-Stahl, E.6
  • 26
    • 54049147790 scopus 로고    scopus 로고
    • Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
    • Rimsza LM, Leblanc ML, Unger JM, et al. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood 2008;112:3425-3433.
    • (2008) Blood , vol.112 , pp. 3425-3433
    • Rimsza, L.M.1    Leblanc, M.L.2    Unger, J.M.3
  • 27
    • 18744383031 scopus 로고    scopus 로고
    • Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma
    • DOI 10.1034/j.1600-0609.2002.02751.x
    • Kuittinen O, Soini Y, Turpeenniemi-Hujanen T. Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma. Eur J Haematol 2002;69:205-212. (Pubitemid 35448125)
    • (2002) European Journal of Haematology , vol.69 , Issue.4 , pp. 205-212
    • Kuittinen, O.1    Soini, Y.2    Turpeenniemi-Hujanen, T.3
  • 29
    • 0033134764 scopus 로고    scopus 로고
    • Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
    • Vacca A, Ribatti D, Presta M, et al. Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999;9:3064-3073. (Pubitemid 29200799)
    • (1999) Blood , vol.93 , Issue.9 , pp. 3064-3073
    • Vacca, A.1    Ribatti, D.2    Presta, M.3    Minischetti, M.4    Iurlaro, M.5    Ria, R.6    Albini, A.7    Bussolino, F.8    Dammacco, F.9
  • 30
    • 0033769087 scopus 로고    scopus 로고
    • Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression
    • Vacca A, Ribatti D, Ria R, et al. Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression. Dev Immunol 2000;7:77-88.
    • (2000) Dev Immunol , vol.7 , pp. 77-88
    • Vacca, A.1    Ribatti, D.2    Ria, R.3
  • 31
    • 0036790181 scopus 로고    scopus 로고
    • Increase in gelatinasespecificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model
    • Arlt M, Kopitz C, Pennington C, et al. Increase in gelatinasespecificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res 2002;62:5543-5550.
    • (2002) Cancer Res , vol.62 , pp. 5543-5550
    • Arlt, M.1    Kopitz, C.2    Pennington, C.3
  • 33
    • 0030825485 scopus 로고    scopus 로고
    • Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma
    • Fisher RI. Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma. Cancer Chemother Pharmacol 1997;40(Suppl):S42-S46.
    • (1997) Cancer Chemother Pharmacol , vol.40 , Issue.SUPPL.
    • Fisher, R.I.1
  • 37
    • 48349126806 scopus 로고    scopus 로고
    • Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma
    • Nyman H, Jantunen E, Juvonen E, et al. Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma. Bone Marrow Transplant 2008;42:93-98.
    • (2008) Bone Marrow Transplant , vol.42 , pp. 93-98
    • Nyman, H.1    Jantunen, E.2    Juvonen, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.